Synthesis and Characterization of Cyclometalated Ruthenium (II) Complexes and Assessment of Their Potential as Pharmaceuticals

Synthesis and Characterization of Cyclometalated Ruthenium (II) Complexes and Assessment of Their Potential as Pharmaceuticals
Author :
Publisher :
Total Pages : 0
Release :
ISBN-10 : OCLC:1430595119
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Synthesis and Characterization of Cyclometalated Ruthenium (II) Complexes and Assessment of Their Potential as Pharmaceuticals by : Leslie Ann Morales

Download or read book Synthesis and Characterization of Cyclometalated Ruthenium (II) Complexes and Assessment of Their Potential as Pharmaceuticals written by Leslie Ann Morales and published by . This book was released on 2022 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Cyclometalated Ruthenium (II) and RAPTA species were synthesized, characterized and evaluated on their photophysical properties and potential as anti-cancer agents. The binding affinity to yeast RNA of one of the newly synthesized compounds containing a thiophene group (LM5400) was compared to its literature precursor (Compound B) containing a phenyl group under gel electrophoresis. Results indicated that the bands of compounds; Compound A, LM3000, Compound B and LM5400 when incubated with yeast RNA, were similar to the control with the expectation of the band of LM5400 being more faint relative to the rest whenever samples were incubated for 24hrs. Photophysical experiments on cyclometalated ruthenium (II) compounds (CompoundA, LM3000, Compound B, LM5400) indicated that these compounds have an absorbance around 360 nm respectively but do not fluoresce due to extremely low emission values. Four hydrolysis studies were done on the cyclometalated ruthenium (II) species under various conditions and monitored via UV/Vis and H-NMR. Underall conditions, the absorbance and the NMR data the complexes with the j6-benzene ring (Compound A and LM3000) changed under aqueous and chloride solutions. In contrast, the absorbance of the complexes with the j6-cymene rings (Compound B and LM5400) only changed upon increased concentration. All compounds synthesized were characterized by NMR. Crystal structures were obtained for newly synthesized compounds, LM3000 and LM5400.


Synthesis and Characterization of Cyclometalated Ruthenium (II) Complexes and Assessment of Their Potential as Pharmaceuticals Related Books

Synthesis and Characterization of Cyclometalated Ruthenium (II) Complexes and Assessment of Their Potential as Pharmaceuticals
Language: en
Pages: 0
Authors: Leslie Ann Morales
Categories: Chemistry, Inorganic
Type: BOOK - Published: 2022 - Publisher:

DOWNLOAD EBOOK

Cyclometalated Ruthenium (II) and RAPTA species were synthesized, characterized and evaluated on their photophysical properties and potential as anti-cancer age
Synthesis and Characterization of Cyclometalated Ruthenium (II) Complexes for Applications in Photoactivated Cancer Therapy
Language: en
Pages: 168
Synthesis and Characterization of Hybrid Drugs Based on Ruthenium Complex Moiety and Biologically Active Organic Compounds
Language: en
Pages: 0
Authors: Michał Pawel Łomzik
Categories:
Type: BOOK - Published: 2016 - Publisher:

DOWNLOAD EBOOK

The main goal of this thesis was synthesis and preliminary characterization of novel ruthenium(II) polypyridyl complexes bearing biologically active molecules a
Ruthenium Chemistry
Language: en
Pages: 386
Authors: Ajay Kumar Mishra
Categories: Science
Type: BOOK - Published: 2018-01-17 - Publisher: CRC Press

DOWNLOAD EBOOK

This book will describe Ruthenium complexes as chemotherapeutic agent specifically at tumor site. It has been the most challenging task in the area of cancer th
Ruthenium(II) Polypyridyl Complexes as Potential Anticancer Drugs
Language: en
Pages:
Authors: Yanling Chen
Categories:
Type: BOOK - Published: 2013 - Publisher:

DOWNLOAD EBOOK

Research on biological activities of ruthenium polypyridyl complexes (RPCs) continues to attract interest as these complexes have shown promising anticancer act